|
|
Article: Emisphere Technologies: Interim Data Indicates Eligen B12 Oral Formulation Gets Similar Results as B12 Injection.(Clinical report)
- Article from:
- Health & Beauty Close-Up
- Article date:
- November 5, 2009
CopyrightCOPYRIGHT 2009 Close-Up Media, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Emisphere Technologies, Inc. has announced that interim data from an ongoing study demonstrated its high-dose oral Eligen B12 (1000mcg) performed as well as or better than B12 injections in individuals with Vitamin B12 deficiency.
In a release, the Company noted:
Normal levels of serum B12 and active B12 were achieved by 100 percent of those study participants who have currently taken Eligen B12 (1000mcg) 15 days into the 90-day study when the first blood samples were taken.
As part of an interim analysis in this randomized, multi-center study, levels of serum B12, active B12, homocysteine and methyl malonic acid were measured on day 15, at ...